- Home
- LRMR vs AMRN Comparison
LRMR vs AMRN Comparison
Compare LRMR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- AMRN
- Stock Information
- Founded
- LRMR N/A
- AMRN 1989
- Country
- LRMR United States
- AMRN Ireland
- Employees
- LRMR N/A
- AMRN N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LRMR Health Care
- AMRN Health Care
- Exchange
- LRMR Nasdaq
- AMRN Nasdaq
- Market Cap
- LRMR 204.9M
- AMRN 216.0M
- IPO Year
- LRMR N/A
- AMRN 1993
- Fundamental
- Price
- LRMR $3.88
- AMRN $15.39
- Analyst Decision
- LRMR Strong Buy
- AMRN Strong Sell
- Analyst Count
- LRMR 7
- AMRN 1
- Target Price
- LRMR $17.86
- AMRN $12.00
- AVG Volume (30 Days)
- LRMR 892.3K
- AMRN 97.6K
- Earning Date
- LRMR 08-06-2025
- AMRN 07-30-2025
- Dividend Yield
- LRMR N/A
- AMRN N/A
- EPS Growth
- LRMR N/A
- AMRN N/A
- EPS
- LRMR N/A
- AMRN N/A
- Revenue
- LRMR N/A
- AMRN $214,112,000.00
- Revenue This Year
- LRMR N/A
- AMRN N/A
- Revenue Next Year
- LRMR N/A
- AMRN N/A
- P/E Ratio
- LRMR N/A
- AMRN N/A
- Revenue Growth
- LRMR N/A
- AMRN N/A
- 52 Week Low
- LRMR $1.61
- AMRN $7.08
- 52 Week High
- LRMR $9.88
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- LRMR 69.65
- AMRN 51.11
- Support Level
- LRMR $3.11
- AMRN $15.11
- Resistance Level
- LRMR $4.01
- AMRN $15.68
- Average True Range (ATR)
- LRMR 0.27
- AMRN 0.54
- MACD
- LRMR 0.03
- AMRN -0.29
- Stochastic Oscillator
- LRMR 85.64
- AMRN 11.55
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.